Zgliczynski S, Baranowska B, Szymanowski J
J Urol (Paris). 1981;87(9):635-8.
The authors examined the influence of spironolactone on the concentration of testosterone, 5 alpha - dihydrotestosterone (DHT), progesterone, oestradiol (E2), LH, and FSH in 47 patients with prostatic hypertrophy, aged from 60 to 80 years. The control group consisted of 58 men of the same age. Spironolactone was prescribed at a dose of 100 mg per day for three months. There was a considerable fall in the concentration of testosterone and of DHT and, at the same time, an increase in the concentration of progesterone, E2 and LH. After treatment with spironolactone there was a decrease in the size of the prostate gland. Results obtained show that spironolactone is an effective drug in the treatment of prostatic hypertrophy, since it inhibits androgen metabolism.
作者研究了螺内酯对47例年龄在60至80岁之间的前列腺肥大患者体内睾酮、5α-二氢睾酮(DHT)、孕酮、雌二醇(E2)、促黄体生成素(LH)和促卵泡生成素(FSH)浓度的影响。对照组由58名同年龄段男性组成。螺内酯的给药剂量为每日100毫克,持续三个月。睾酮和DHT的浓度显著下降,与此同时,孕酮、E2和LH的浓度升高。使用螺内酯治疗后,前列腺体积减小。所得结果表明,螺内酯是治疗前列腺肥大的有效药物,因为它能抑制雄激素代谢。